Furthermore, TGFβ upregulates expression of NK cell inhibitory receptors while at the same time downregulating activating receptors such as NKp30 and NKG2D or their respective ligands, such as MHC class I polypeptide-related sequence A (MICA), on cancer cells [47,48]. The gene discussed is TGFB1; the disease is cancer.